Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

296 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Completed

Disease-Modifying Treatments for Myasthenia Gravis

NCT03490539

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Stanford University Palo Alto, California, United States
  • Unversity of Miami Miami, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 19 locations
View Trial Details
Completed

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

NCT06002945

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +18 more
Locations
  • University of California-Irvine Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • George Washington University Washington D.C., District of Columbia, United States
View Trial Details
Completed

An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasthenia Gravis

NCT04980495

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +13 more
Locations
  • Investigator Site 10 - US0010007 Carlsbad, California, United States
  • Investigator Site 7 - US0010001 Orange, California, United States
  • Investigator Site 9 - 0010006 Boca Raton, Florida, United States
  • Investigator Site 15 - US0010014 Coral Springs, Florida, United States
View all 39 locations
View Trial Details
Completed

A Study to Evaluate the Safe and Effective Use of a Zilucoplan Auto-injector by Study Participants With Generalized Myasthenia Gravis

NCT06471361

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Dv0013 50628 New Haven, Connecticut, United States
  • Dv0013 50634 Tampa, Florida, United States
  • Dv0013 50648 Columbia, Missouri, United States
  • Dv0013 50556 Chapel Hill, North Carolina, United States
View Trial Details
Completed

Evaluating the Long-Term Safety and Tolerability of Efgartigimod PH20 SC Administered Subcutaneously in Patients With Generalized Myasthenia Gravis

NCT04818671

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Investigator site 6 - US0010032 Carlsbad, California, United States
  • Investigator Site 47 - US0010021 Palo Alto, California, United States
  • Investigator Site 45 - US0010108 Boca Raton, Florida, United States
  • Investigator site 4 - US0010110 Port Charlotte, Florida, United States
View all 47 locations
View Trial Details

Related conditions